跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hospira ANZATAX Paclitaxel 30 mg/5 mL Injection vial – Asia - TGA Drug Approval Details
Approvals
/
TGA
/
Hospira ANZATAX Paclitaxel 30 mg/5 mL Injection vial – Asia
Approved
STANDARD
Hospira ANZATAX Paclitaxel 30 mg/5 mL Injection vial – Asia
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fe0ab4b5b76130bf
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
fe0ab4b5b76130bf
Product Name
Hospira ANZATAX Paclitaxel 30 mg/5 mL Injection vial – Asia
Artg Id
391415
Artg Name
Hospira ANZATAX Paclitaxel 30 mg/5 mL Injection vial – Asia
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2022-06-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fe0ab4b5b76130bf
Type
Standard
Back to TGA Approvals
